Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $15.70 in the prior trading day, Arcus Biosciences Inc (NYSE: RCUS) closed at $14.43, down -8.09%. In other words, the price has decreased by -$8.09 from its previous closing price. On the day, 0.69 million shares were traded. RCUS stock price reached its highest trading level at $15.73 during the session, while it also had its lowest trading level at $14.35.
Ratios:
Our goal is to gain a better understanding of RCUS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.23 and its Current Ratio is at 5.23. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 21, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On October 08, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $29.
On November 18, 2022, BofA Securities started tracking the stock assigning a Neutral rating and target price of $33.BofA Securities initiated its Neutral rating on November 18, 2022, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 13 ’24 when Azoy Alexander sold 1,357 shares for $14.97 per share. The transaction valued at 20,314 led to the insider holds 19,070 shares of the business.
Jarrett Jennifer sold 11,551 shares of RCUS for $202,720 on Mar 27 ’24. The Chief Operating Officer now owns 215,253 shares after completing the transaction at $17.55 per share. On Mar 18 ’24, another insider, Jarrett Jennifer, who serves as the Chief Operating Officer of the company, sold 13,449 shares for $17.92 each. As a result, the insider received 240,941 and left with 226,804 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCUS now has a Market Capitalization of 1320512384 and an Enterprise Value of 426732256. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.00 while its Price-to-Book (P/B) ratio in mrq is 2.34. Its current Enterprise Value per Revenue stands at 1.623 whereas that against EBITDA is -1.482.
Stock Price History:
Over the past 52 weeks, RCUS has reached a high of $20.31, while it has fallen to a 52-week low of $13.49. The 50-Day Moving Average of the stock is -12.98%, while the 200-Day Moving Average is calculated to be -12.00%.
Shares Statistics:
The stock has traded on average 712.53K shares per day over the past 3-months and 927670 shares per day over the last 10 days, according to various share statistics. A total of 75.50M shares are outstanding, with a floating share count of 48.11M. Insiders hold about 47.43% of the company’s shares, while institutions hold 54.43% stake in the company. Shares short for RCUS as of 1730332800 were 6652735 with a Short Ratio of 9.34, compared to 1727654400 on 6611526. Therefore, it implies a Short% of Shares Outstanding of 6652735 and a Short% of Float of 14.99.
